Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: reglan / benzodiazepines attending: chief complaint: seizure major surgical or invasive procedure: hemodialysis fistula placement tunnel catheter for hemodialysis in rij history of present illness: hpi: mrs. is a 47 year old female with esrd on hd since , iddm, and seizure d/o who was taken to the er today after experiencing a seizure with 9 minutes left of her dialysis. she has a known hx of sz d/o and is followed by dr. in neurology. she has been maintained on tegretol 200 mg qid and had been seizure-free for over a year until last thursday. she seized that day and was seen at , where she was reportedly hypoglycemic to 30; her sz was attributed to that. today, she had a witnessed seizure with tonic clonic activity, fecal incontinence, and a post-ictal state during hd. her glucose was reportedly 140 at hd. in the er, she was hypertensive at 240/108, which lowered to 216/97 after metoprolol 2.5 mg. she was also given cefazolin 1 g, which she has taken for the last 10 days since her admission here () for mssa bacteremia infected graft. she was about to be discharged from the er when she became lethargic and diaphoretic. her fingerstick was 30. she received an amp of d50 and it was decided to admit her. she reports that she has had more trouble controlling her glucose since the recent admission, when her glargine dose was adjusted. her sbp remained over 200 throughout her time in the er. a head ct was negative for acute bleed, and her tegretol level was subtherapeutic at 3.0. her fingerstick later was 403, for which she received 14 units of regular insulin. since her recent admission, she reports that she has been nauseous, which she attributed to her abx treatment. she denied any fevers or chills, chest pain, pain at graft or temp hd cath sites, shortness of breath, abd pain, or vomiting/diarrhea. she did state that she's been having headaches for the past 2 weeks, but denied visual changes, weakness or parasthesias. past medical history: past med hx: 1. esrd on hd: received lrd in from father, but went back on hd in due to chronic allograft nephropathy. is currently listed for kidney/pancreas transplant. 2. iddm: with diabetic nephropathy and retinopathy. 3. infected fistula: admitted with mssa bacteremia, rx with oxacillin and then 10 days ancef. has temp hd access in r ij. was supposed to have appt today with transplant surgeons to address this. 4. htn: had emalapril adjusted during hospital stay, to 20 mg qd from 5 per her report. 6. seizure d/o: on tegretol, followed by dr. 7. angioplasty of upper extremity veins: has hx of clots in subclavian and brachiocephalic veins, s/p stenting. latest stent was wks ago per pt. 8. mi dx'ed by ekg: no chest pain. social history: lives with husband and 2 adopted children, age 14 and 18. works as school teacher. family history: fam hx: father with cad, mother with thyroid problem, sister with . no fam hx sz d/o. physical exam: t: 98.6 bp: 150/90 p: 72 r: 18 98% on ra weight: 103.8 lbs gen: awake and alert, looks uncomfortable but is oriented and appropriate heent: periorbital edema, perrl, eomi, op clr without lesion, jvd 5-6 cm, no carotid bruits chest: r sc temp hd cath site nontender, no edema/erythema lungs: cta bilaterally, no wheezes/rhonchi/crackles cv: rrr, no murmurs/rubs/gallops abd: soft, nt/nd. +bs. no hsm. kidney graft nontender. ext: lue fistula without edema/erythema/tenderness. no thrill or bruit. 1+ distal pulses, no edema. neuro: cnii-xii grossly intact. strength symmetric and in upper and lower extremities pertinent results: 10:50am plt count-264 10:50am hypochrom-1+ anisocyt-1+ macrocyt-3+ 10:50am neuts-71.1* lymphs-15.2* monos-4.8 eos-7.6* basos-1.2 10:50am wbc-4.3 rbc-3.86* hgb-13.1 hct-40.2 mcv-104* mch-34.0* mchc-32.7 rdw-16.1* 10:50am carbamzpn-3.0* 10:50am glucose-114* urea n-30* creat-4.6* sodium-143 potassium-4.1 chloride-96 total co2-29 anion gap-22* brief hospital course: in house, patient received hemodialisis and was educated on better glycemic control. seizures were thought to most likely be due to hypoglycemia vs. subtherapeutic tegretol dosing. throughout the course, pt became less somnolent, and after several days of hd and strict glucose control with seizure medications, pt still had labile blood sugars with an epsisode of unresponiveness on the floor. pt was transferred to micu for closer glucose control. avg graft revision done successfully on . pt returned to floor after successful control of blood sugars and was discharged after pt able to take in po's with stable sugars. medications on admission: tegretol 200 mg qid sertraline 100 mg qd lipitor 10 mg qd calcium carbonate 500 mg tid prednisone 3 mg qam, 1 mg qhs asa ec 325 mg qd renagel 800 mg tid ac lopressor 50 mg enalapril 20 mg qd ranitidine 150 mg glargine 12 units qd ancef discharge medications: 1. carbamazepine 200 mg tablet sig: one (1) tablet po qid (4 times a day). 2. sertraline hcl 100 mg tablet sig: one (1) tablet po qd (once a day). 3. atorvastatin calcium 10 mg tablet sig: one (1) tablet po qd (once a day). 4. calcium carbonate 500 mg tablet, chewable sig: one (1) tablet, chewable po tid (3 times a day) as needed. 5. prednisone 1 mg tablet sig: three (3) tablet po qam (once a day (in the morning)). 6. prednisone 1 mg tablet sig: one (1) tablet po hs (at bedtime). 7. aspirin 325 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po qd (once a day). 8. prochlorperazine 10 mg tablet sig: one (1) tablet po q6h (every 6 hours) as needed. 9. ranitidine hcl 150 mg tablet sig: one (1) tablet po qd (once a day). 10. sevelamer hcl 800 mg tablet sig: two (2) tablet po tid (3 times a day) as needed for with meals. 11. zolpidem tartrate 5 mg tablet sig: one (1) tablet po hs (at bedtime). 12. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 13. enalapril maleate 10 mg tablet sig: two (2) tablet po bid (2 times a day). 14. insulin glargine 100 unit/ml solution sig: eight (8) units subcutaneous at bedtime. 15. toprol xl 100 mg tablet sustained release 24hr sig: 1.5 tablet sustained release 24hrs po once a day. disp:*45 tablet sustained release 24hr(s)* refills:*0* 16. compazine 10 mg tablet sig: one (1) tablet po once a day. disp:*30 tablet(s)* refills:*0* 17. insulin regular human 300 unit/3 ml syringe sig: as directed units subcutaneous per sliding scale: for blood sugar of 81-150: no insulin 151-200: 1 unit at breakfast, 1 unit at lunch, 1 unit at dinner, 0 at bedtime. bs 201-250: give 2 units at breakfast, 2 units at lunch, 2 units at dinner, and 1 unit at bedtime. bs 251-300: give 3 units at breakfast, 3 units at lunch, 3 units at dinner, and 2 units at bedtime. bs 301-350: 4 units at breakfast, 4 units at lunch, 4 units at dinner, and 3 units at bedtime. bs 351-400: 5 units at breakfast, lunch and dinner, and 4 units at bedtime. discharge disposition: home discharge diagnosis: 1. esrd on hd 2. t1dm 3. htn 4. cad 5. seizure d/o discharge condition: stable discharge instructions: 1. please take your medications 2. please be very vigilant about maintaining your blood sugars!! you should be checking your blood sugars at least every 4 hours. 3. please go to all your follow up appointments, see below. 4. if you feel nauseated, have uncontrollable vomiting, headaches, fevers, chills, dizziness, pain with urination, or more seizures, come back to the emergency department immediately. followup instructions: follow up with your primary care doctors: provider: , md where: phone: date/time: 3:00 follow up at the transplant center: provider: , transplant center (nhb) where: lm clinic phone: date/time: 1:00 test to evaluate nausea and vomiting: friday, at 2:00 pm on the of bldg. please do not eat anything for 4 hours prior to study procedure: hemodialysis venous catheterization for renal dialysis revision of arteriovenous shunt for renal dialysis diagnoses: nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere coronary atherosclerosis of native coronary artery other convulsions hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease personal history of venous thrombosis and embolism other complications due to renal dialysis device, implant, and graft diabetes with renal manifestations, type i [juvenile type], uncontrolled diabetes with other specified manifestations, type i [juvenile type], uncontrolled 

Answer: The patient is high likely exposed to